Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Response Biomed Corp RPBIF

"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."


GREY:RPBIF - Post by User

Bullboard Posts
Post by dimar66on Sep 03, 2011 12:50am
358 Views
Post# 19009276

Goodbye Roche

Goodbye RocheGoodbye Roche and thanks for nothing.  Roche has their own testing platforms; they have just been playing us around.  This won't hurt our bottom line, they have been doing nothing anyway.  All of a sudden we hear that our Ramp 200 needs FDA approval, why hasn't Roche done something to move this forward, or why didn't Kay take some initiative on this?
"Response has not obtained the necessary approvals from the U.S. Food and Drug Administration (FDA) to permit Roche Diagnostics to market Response’s cardiovascular POC tests in the United States using the RAMP® 200 Reader"
" Response does not expect the termination of its agreement with Roche Diagnostics to have a material impact on its financial results for the current year.
OF COARSE NOT, THEY HAVE BEEN DOING BUGGER ALL ANYWAY!
Bullboard Posts